TELADOC HEALTH INC
TDOCNYSETrading Snapshot
- Day Range
- $538.48 β $547.64
- 52-Week Range
- $4.40 β $9.89
- Volume
- $2.00B
- Avg Volume
- $2.54B
- Shares Outstanding
- 181.7M
- Next Earnings
- Nov 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.53B
- Last Q Revenue
- $607M
- P/E Ratio
- -6.2
- P/S Ratio
- 0.4x
- EPS (TTM)
- $-0.99
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +2.0%
Why Investors Own TDOC
- βHigh-growth profile β revenue up -0.9% YoY with expanding US Equity exposure.
- βHealthy economics β 60% gross margin and 14% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
TELADOC HEALTH INC
TDOCAbout TELADOC HEALTH INC
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
TELADOC HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift TDOC price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
TELADOC HEALTH INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.